Stay updated on Belapectin for Esophageal Varices in NASH Cirrhosis Clinical Trial
Sign up to get notified when there's something new on the Belapectin for Esophageal Varices in NASH Cirrhosis Clinical Trial page.

Latest updates to the Belapectin for Esophageal Varices in NASH Cirrhosis Clinical Trial page
- Check4 days agoChange DetectedVersion update from v3.0.1 to v3.0.2; removal of the 'Back to Top' element. Core content remains effectively the same.SummaryDifference0.5%
- Check11 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.SummaryDifference0.5%
- Check18 days agoChange DetectedThe web page has added a facility name and location details, while removing specific location terms and references to states, countries, and cities. This indicates a shift towards a more streamlined presentation of location information.SummaryDifference60%
- Check26 days agoNo Change Detected
- Check33 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.3%
- Check40 days agoChange DetectedThe web page has been updated from version 2.16.10 to version 2.16.11.SummaryDifference0.3%
- Check47 days agoChange DetectedThe page has been updated to include new information about a clinical study evaluating the efficacy and safety of Belapectin for the prevention of esophageal varices in NASH cirrhosis, sponsored by Galectin Therapeutics Inc.SummaryDifference76%
Stay in the know with updates to Belapectin for Esophageal Varices in NASH Cirrhosis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Belapectin for Esophageal Varices in NASH Cirrhosis Clinical Trial page.